Oppenheimer Resumes Centessa Pharmaceuticals (CNTA) at Outperform
Tweet Send to a Friend
(Updated - August 29, 2025 6:32 AM EDT)
Oppenheimer analyst Jay Olson resumes coverage on Centessa Pharmaceuticals (NASDAQ: CNTA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jay Olson resumes coverage on Centessa Pharmaceuticals (NASDAQ: CNTA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


